Similar posts:

• 
  Xeomin: analysis of aesthetic use experience

  Who chooses botulinum toxin type A — Xeomin? Who can it be recommended for? Features of correction in different areas of the face and neck. Injection technique guidance and possible adverse effects.

• 
  AbbVie Submits Biologics License Application to U.S. FDA of a new botulinum toxin type E

  AbbVie has submitted an application to the FDA for the approval of TrenibotE — the first-in-class botulinum toxin type E. The product demonstrates a record-fast onset of action (8 hours) and a short duration of effect (2-3 weeks), which may change the approach to initial injections in patients who have previously avoided neurotoxins.

• 
  Botulinum Toxin in Cosmetology – Poison or Medicine?

  In recent years, botulinum toxin preparations have gained popularity as a means of smoothing out expression lines — wrinkles caused by excessive activity of the facial muscles. But is Botox really dangerous, and what do we actually know about it?